Invasive Haemophilus influenzae type b (Hib) disease has become exceedingly rare in adults following universal childhood vaccination. This decline, while a triumph of public health, poses a diagnostic challenge: clinical suspicion and laboratory protocols may not be optimized for its detection. A new systematic review published in BMC Infectious Diseases by Liu and colleagues characterizes adult frontal osteomyelitis caused by H. influenzae in the post-vaccination era, with an emphasis on the diagnostic challenges and therapeutic implications of a rare index Hib case.
The authors conducted a systematic literature review in accordance with the PRISMA 2020 guidelines, searching PubMed, Embase and Web of Science from database inception to February 28, 2026. They analyzed a contemporary index case of an elderly man with Hib frontal osteomyelitis in depth alongside retrieved historical cases. Descriptive and comparative synthesis was performed for the collected data. Eight cases were analyzed in total. Seven historical cases, all caused by non-type b strains, all required surgical debridement. The index case was the first reported Hib-induced frontal osteomyelitis in an elderly adult in two decades.
Initial culture of abscess fluid using only blood and MacConkey agars failed, despite a positive Gram stain. Diagnosis was achieved only after bedside inoculation that included chocolate agar, yielding a β-lactamase-negative Hib strain susceptible to amoxicillin/clavulanate. Consequently, the patient was successfully cured with targeted antibiotic therapy alone, without surgical intervention, and has remained asymptomatic for more than 4 years to date. This finding reinforces that standard culture protocols including chocolate agar should be followed for Gram-stain-positive sterile-site specimens to recover fastidious organisms. Observations regarding non-surgical antibiotic-only management remain hypothesis-generating and require further validation.
Frontal osteomyelitis is a serious infection of the frontal bone, often associated with Pott’s puffy tumor, and typically arises as a complication of frontal sinusitis. The systematic review characterizes invasive Hib disease among vulnerable adults in the post-vaccination era based on a rare index case successfully managed without surgical debridement. The findings carry significant technical weight for clinical microbiology laboratories: fastidious organisms such as H. influenzae require enriched media like chocolate agar for recovery, and standard culture protocols must be followed for Gram-stain-positive sterile-site specimens.
The index case demonstrates that targeted antibiotic therapy alone can be curative in selected cases of Hib frontal osteomyelitis, potentially avoiding the morbidity of surgical debridement. However, all seven historical cases of non-type b H. influenzae frontal osteomyelitis required surgical debridement, highlighting the importance of accurate microbiological diagnosis in guiding therapeutic decisions. The β-lactamase-negative status of the Hib strain and its susceptibility to amoxicillin/clavulanate were crucial in enabling successful non-surgical management.
This research was financially supported by the Medical Research Project of Chengdu (No.2024281) and the Medical Research Project of Chengdu (No.2024544). The retrospective case study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of The General Hospital of Western Theater Command. The requirement for informed consent was waived by the Institutional Review Board. The authors declare no competing interests.
The systematic review and index-case analysis offer a compelling narrative for the post-vaccination era, where Hib disease among vulnerable adults remains a diagnostic challenge. The technical lessons from this case—particularly the importance of chocolate agar in recovering fastidious organisms from sterile sites—carry broad relevance for clinical microbiology practice. The successful non-surgical management of the index case, with more than 4 years of asymptomatic follow-up, provides a hypothesis-generating observation that warrants further validation in larger cohorts.
In summary, Liu and colleagues have characterized adult frontal osteomyelitis caused by H. influenzae in the post-vaccination era through a systematic review plus index-case analysis. The findings reinforce that standard culture protocols including chocolate agar should be followed for Gram-stain-positive sterile-site specimens to recover fastidious organisms. Observations regarding non-surgical antibiotic-only management remain hypothesis-generating and require further validation. The research offers a rare and valuable contribution to the understanding of invasive Hib disease among vulnerable adults in the post-vaccination era.
Beyond the immediate diagnostic lesson, the case underscores a broader shift in the epidemiology of invasive Haemophilus influenzae disease. Before the introduction of conjugate Hib vaccines, type b strains were the leading cause of invasive H. influenzae infections in children, including meningitis, epiglottitis, septic arthritis, and cellulitis. Universal childhood immunization has driven type b disease to near-elimination levels in countries with high vaccine coverage, and as a consequence, the residual burden of invasive H. influenzae disease now falls predominantly on non-type b capsular types and on untypeable strains. Adults, particularly the elderly and those with underlying comorbidities, have become the principal population in which invasive H. influenzae infections are encountered, which helps explain why the seven historical cases compiled in this review were all caused by non-type b strains.
The rarity of Hib osteomyelitis in an elderly adult is what makes the index case noteworthy. Skeletal infections caused by H. influenzae were historically considered almost exclusively a disease of young children, and frontal bone involvement in adults has been reported only sporadically. The authors’ observation that this is the first reported Hib-induced frontal osteomyelitis in an elderly adult in two decades illustrates how thoroughly the organism has vanished from the differential diagnosis of adult skull infections. When clinicians and microbiologists no longer expect to encounter an organism, the systems built to detect it can quietly erode, and this case provides a concrete example of that erosion in laboratory practice.
The microbiological detail at the heart of the report deserves emphasis. H. influenzae is a fastidious, gram-negative coccobacillus that requires both X factor (hemin) and V factor (NAD) for growth, factors that are supplied by enriched media such as chocolate agar but are absent from unsupplemented blood agar, where the organism’s growth is inhibited. MacConkey agar, a selective and differential medium designed for enteric gram-negative bacilli, does not support H. influenzae at all. A culture workup limited to blood and MacConkey agars is therefore structurally incapable of recovering the organism, even when the Gram stain clearly shows bacteria. The positive Gram stain in this case was the critical signal that prompted escalation to bedside inoculation with chocolate agar, which ultimately yielded the diagnosis. Bedside or direct inoculation matters for an additional reason: delays in processing sterile-site specimens can compromise the viability of fastidious organisms, so plating at the point of collection maximizes recovery.
The antimicrobial susceptibility profile of the recovered strain also shaped the therapeutic course. The isolate was β-lactamase-negative and susceptible to amoxicillin/clavulanate, allowing oral or targeted beta-lactam-based therapy without the empiric broadening that is often applied when susceptibility data are unavailable. In an era when H. influenzae resistance varies regionally, obtaining an isolate rather than relying solely on molecular detection preserves the ability to perform susceptibility testing, which in this case was decisive in supporting a non-surgical strategy.
The contrast between the index case and the historical cases raises questions about the role of microbiological diagnosis in treatment selection. All seven historical cases of non-type b H. influenzae frontal osteomyelitis required surgical debridement, whereas the index patient was cured with antibiotics alone and remained asymptomatic for more than four years. The authors are appropriately cautious, framing the antibiotic-only observation as hypothesis-generating rather than practice-changing. Frontal osteomyelitis with associated Pott’s puffy tumor has traditionally been managed with a combination of surgical source control and prolonged antimicrobial therapy, and the possibility that early, targeted therapy against a fully susceptible organism might obviate surgery in selected patients is an intriguing but unproven proposition. Factors such as the extent of bone involvement, the presence of abscess, the timing of diagnosis, and host factors would all need systematic evaluation before any change in practice could be considered.
For clinical microbiology laboratories, the report serves as a reminder that culture protocols optimized for the pre-vaccination era should not be dismantled simply because the epidemiology has shifted. Gram-stain-positive sterile-site specimens, including abscess fluids, joint aspirates, and cerebrospinal fluids, warrant a full standard workup that includes enriched media capable of supporting fastidious organisms. Laboratories that have trimmed chocolate agar from routine inoculation panels in the interest of efficiency may inadvertently create blind spots for organisms like H. influenzae, and this case demonstrates how such a blind spot can delay diagnosis and push clinicians toward more invasive interventions.
More broadly, the study illustrates the value of pairing a contemporary case with a systematic review of the literature. By situating a single index case within the full published record of adult H. influenzae frontal osteomyelitis, the authors were able to identify patterns—such as the uniform need for surgery among historical non-type b cases—that no single report could establish on its own. This approach is particularly useful for rare diseases, where randomized trials are infeasible and the accumulated case literature constitutes the primary evidence base. The PRISMA 2020 framework applied here provides a transparent structure for such synthesis, and the comparative analysis of the index case against its historical predecessors gives the report analytical weight beyond that of a simple case description.
Finally, the report highlights the continuing relevance of Hib vaccination to adult medicine. Herd protection from childhood immunization has dramatically reduced Hib disease across all age groups, but waning or incomplete immunity, changing capsular types, and vulnerable adult populations mean that type b disease has not disappeared entirely. Clinicians evaluating adults with frontal bone infections, Pott’s puffy tumor, or other invasive syndromes should retain H. influenzae in the differential diagnosis, and microbiologists should maintain the laboratory capability to recover and identify it. The lessons from this case—chocolate agar for Gram-stain-positive sterile sites, bedside inoculation for fastidious organisms, and susceptibility testing to guide therapy—are simple, inexpensive, and applicable in laboratories worldwide.
Subject of Research: Haemophilus influenzae type b frontal osteomyelitis diagnosis and management in the post-vaccination era
Article Title: Overcoming diagnostic pitfalls of Haemophilus influenzae type b frontal osteomyelitis: a systematic review plus index-case analysis in the post-vaccination era
Article References: Liu, L., Wang, L., Tan, J., Hu, Z., Qu, Y., Duan, J., & Liu, Y. (2026). Overcoming diagnostic pitfalls of Haemophilus influenzae type b frontal osteomyelitis: a systematic review plus index-case analysis in the post-vaccination era. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14443-8
Image Credits: AI Generated
DOI: 10.1186/s12879-026-14443-8
Keywords: Haemophilus influenzae type b, frontal osteomyelitis, chocolate agar, sterile-site culture, systematic review, post-vaccination era, diagnostic pitfalls, Overcoming, diagnostic, pitfalls, Haemophilus, influenzae
Cite Scienmag News
Ophelia Keating. (October 19, 2026). Rare Hib frontal osteomyelitis in an elderly adult exposes diagnostic pitfalls in the post-vaccination era. Scienmag. https://scienmag.com/rare-hib-frontal-osteomyelitis-in-an-elderly-adult-exposes-diagnostic-pitfalls-in-the-post-vaccination-era/
Ophelia Keating. "Rare Hib frontal osteomyelitis in an elderly adult exposes diagnostic pitfalls in the post-vaccination era." Scienmag, 19 October 2026, https://scienmag.com/rare-hib-frontal-osteomyelitis-in-an-elderly-adult-exposes-diagnostic-pitfalls-in-the-post-vaccination-era/. Accessed 19 October 2026.
Ophelia Keating. "Rare Hib frontal osteomyelitis in an elderly adult exposes diagnostic pitfalls in the post-vaccination era." Scienmag. October 19, 2026. https://scienmag.com/rare-hib-frontal-osteomyelitis-in-an-elderly-adult-exposes-diagnostic-pitfalls-in-the-post-vaccination-era/

